BSPP (drug)
BSPP (N-benzyl-2-(2,3-dihydro-1,4-benzodioxin-2-ylmethylsulfanyl)-3,5-difluorobenzamide) is a chemical compound that acts as a positive allosteric modulator of the GABAB receptor. It is used primarily in scientific research to study the function and pharmacology of the GABAB receptor.
Chemical Structure and Properties
BSPP is characterized by its unique chemical structure, which includes a benzodioxin ring, a benzyl group, and a difluorobenzamide moiety. The presence of these groups contributes to its activity as a modulator of the GABAB receptor.
Mechanism of Action
As a positive allosteric modulator, BSPP binds to a site on the GABAB receptor that is distinct from the binding site of the endogenous ligand, gamma-Aminobutyric acid (GABA). By binding to this allosteric site, BSPP enhances the receptor's response to GABA, leading to increased inhibitory neurotransmission.
Research Applications
BSPP is used in neuroscience research to investigate the role of GABAB receptors in various physiological and pathological processes. It has been employed in studies examining synaptic plasticity, pain modulation, and neuroprotection. Additionally, BSPP has been used to explore the potential therapeutic benefits of GABAB receptor modulation in conditions such as epilepsy, anxiety, and depression.
Pharmacokinetics
The pharmacokinetic properties of BSPP, including its absorption, distribution, metabolism, and excretion, are important for understanding its effects in vivo. Studies have shown that BSPP can cross the blood-brain barrier, allowing it to exert its effects on central nervous system GABAB receptors.
Safety and Toxicology
As with any research chemical, the safety and toxicology profile of BSPP must be carefully considered. While it is generally used in controlled laboratory settings, information on its long-term effects and potential toxicity in humans is limited.
See Also
- GABAB receptor
- Allosteric modulator
- Neurotransmission
- Synaptic plasticity
- Epilepsy
- Anxiety
- Depression
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD